Showing results (671-680 of 799) with videos related to

Sort By:
Pageof 80
Leukemia & Lymphoma|November 9, 2001
Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group studyJ H Laver, H Mahmoud, T E Pick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposideN J Winick, R W McKenna, J J Shuster, et al.
Diabetes Care|November 25, 2004
Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetesMichael J Haller, Margaret Samyn, Wilmer W Nichols, et al.
Clinical and Experimental Immunology|October 15, 2015
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetesM J Haller, M A Atkinson, C H Wasserfall, et al.
Blood|September 26, 2000
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 casesN R Schneider, A J Carroll, J J Shuster, et al.
Blood|June 15, 1992
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group studyM B Harris, J J Shuster, A Carroll, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Blood|July 1, 1990
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group studyW M Crist, A J Carroll, J J Shuster, et al.
Bioanalysis|February 5, 2021
Quantification of surrogate monoclonal antibodies in mouse serum using LC-MS/MSJohn T Mehl, France Landry, Lorell Discenza, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Pageof 80